Nifty
Sensex
:
:
15752.05
52907.93
-28.20 (-0.18%)
-111.01 (-0.21%)

Pharmaceuticals & Drugs

Rating :
57/99

BSE: 524652 | NSE: INDSWFTLTD

11.00
01-Jul-2022
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 10.90
  • 11.00
  • 10.50
  • 10.65
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  4812
  •  0.52
  •  18.50
  •  4.65

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 57.85
  • N/A
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,051.40
  • N/A
  • -0.08

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 55.58%
  • 8.52%
  • 30.61%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 5.29%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 6.24
  • 7.20

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 30.94

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -39.38
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -0.06
  • -0.06
  • -0.06

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.53
  • 28.36
  • 29.36

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Jun 21
Jun 20
Var%
Net Sales
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Expenses
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBITDA
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Interest
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Depreciation
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PBT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Tax
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PAT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 18
Mar 17
Mar 16
Net Sales
-
269.81
263.05
304.33
Net Sales Growth
-
2.57%
-13.56%
 
Cost Of Goods Sold
-
154.15
166.03
220.48
Gross Profit
-
115.66
97.03
83.85
GP Margin
-
42.87%
36.89%
27.55%
Total Expenditure
-
263.52
328.46
461.28
Power & Fuel Cost
-
11.10
10.43
10.89
% Of Sales
-
4.11%
3.97%
3.58%
Employee Cost
-
44.67
38.79
36.77
% Of Sales
-
16.56%
14.75%
12.08%
Manufacturing Exp.
-
12.93
9.53
8.58
% Of Sales
-
4.79%
3.62%
2.82%
General & Admin Exp.
-
25.28
63.95
50.40
% Of Sales
-
9.37%
24.31%
16.56%
Selling & Distn. Exp.
-
3.15
3.50
4.16
% Of Sales
-
1.17%
1.33%
1.37%
Miscellaneous Exp.
-
12.23
36.24
130.01
% Of Sales
-
4.53%
13.78%
42.72%
EBITDA
-
6.29
-65.41
-156.95
EBITDA Margin
-
2.33%
-24.87%
-51.57%
Other Income
-
14.57
13.68
12.51
Interest
-
11.46
16.32
18.97
Depreciation
-
34.63
35.73
36.35
PBT
-
-25.23
-103.77
-199.77
Tax
-
0.75
0.89
0.17
Tax Rate
-
-1.41%
-0.24%
-0.09%
PAT
-
-54.13
-364.27
-199.94
PAT before Minority Interest
-
-54.13
-364.27
-199.94
Minority Interest
-
0.00
0.00
0.00
PAT Margin
-
-20.06%
-138.48%
-65.70%
PAT Growth
-
-
-
 
EPS
-
-9.99
-67.21
-36.89

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 18
Mar 17
Mar 16
Shareholder's Funds
-663.18
-615.50
-245.43
Share Capital
25.03
25.03
24.27
Total Reserves
-688.21
-640.54
-276.38
Non-Current Liabilities
679.69
672.22
679.33
Secured Loans
651.65
644.57
647.04
Unsecured Loans
15.34
20.20
24.61
Long Term Provisions
5.66
2.64
2.04
Current Liabilities
598.24
607.85
620.93
Trade Payables
166.30
161.76
175.38
Other Current Liabilities
57.90
62.57
74.30
Short Term Borrowings
374.04
383.52
371.25
Short Term Provisions
0.00
0.00
0.00
Total Liabilities
614.75
664.57
1,054.83
Net Block
310.68
342.31
374.14
Gross Block
576.33
576.38
572.52
Accumulated Depreciation
265.65
234.06
198.37
Non Current Assets
428.64
458.13
433.29
Capital Work in Progress
0.00
2.22
3.67
Non Current Investment
45.90
39.41
39.17
Long Term Loans & Adv.
72.06
74.19
16.31
Other Non Current Assets
0.00
0.00
0.00
Current Assets
186.11
206.43
611.65
Current Investments
0.00
0.00
0.00
Inventories
45.44
39.06
90.94
Sundry Debtors
83.50
108.48
380.33
Cash & Bank
3.68
9.11
17.39
Other Current Assets
53.49
6.97
13.05
Short Term Loans & Adv.
47.82
42.81
109.93
Net Current Assets
-412.13
-401.42
-9.29
Total Assets
614.75
664.56
1,054.83

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
7.17
-1.72
-119.44
PBT
-50.43
-371.81
-213.42
Adjustment
73.87
321.14
168.51
Changes in Working Capital
-16.28
48.95
-74.54
Cash after chg. in Working capital
7.17
-1.72
-119.44
Interest Paid
0.00
0.00
0.00
Tax Paid
0.00
0.00
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
Cash From Investing Activity
-6.42
4.14
9.64
Net Fixed Assets
2.27
-2.41
Net Investments
-0.01
1.22
Others
-8.68
5.33
Cash from Financing Activity
-6.17
-10.71
110.21
Net Cash Inflow / Outflow
-5.43
-8.28
0.41
Opening Cash & Equivalents
9.11
17.39
16.98
Closing Cash & Equivalent
3.68
9.11
17.39

Financial Ratios

Standalone /

Consolidated
Description
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
-125.06
-116.26
-54.86
ROA
-8.46%
-42.37%
-18.95%
ROE
0.00%
0.00%
0.00%
ROCE
-10.34%
-56.70%
-22.84%
Fixed Asset Turnover
0.47
0.47
0.54
Receivable days
129.49
333.86
451.08
Inventory Days
56.99
88.79
107.86
Payable days
221.40
227.19
199.14
Cash Conversion Cycle
-34.91
195.46
359.81
Total Debt/Equity
-1.57
-1.70
-4.00
Interest Cover
-3.66
-21.27
-9.53

News Update:


  • Ind-Swift launches cardio diabetic & antibiotic products in Qatar
    3rd Jun 2022, 16:26 PM

    Ind-Swift is also supplying its products in market of Iraq & Yemen and making available quality products at an affordable price to customers

    Read More
  • Ind-Swift incorporates wholly owned subsidiary company
    16th May 2022, 10:00 AM

    The object of setting up a wholly owned subsidiary in the Republic of Kenya is to facilitate the promotion of the Company's products in Kenya

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.